Massive Bio Onboards Over 100,000 Cancer Patients


Massive Bio announced that the company exceeded its goal to onboard 100,000 cancer patients in its platform by the end of 2022. The Massive Bio platform matches cancer patients with relevant clinical trials using AI.

Read more about the platform and its enrollment here.


Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.